11.27.24 -- CEO Panel Talks IRA Impact At Galien Forum

Rita Johnson-Greene, COO at ARM, joined Cell & Gene: The Podcast Host, Erin Harris, on-site during the 2024 Meeting on the Mesa. Listen in as they discuss the Joint Clinical Assessment (JCA) in Europe and its potential impact on cell and gene therapies, how globalization impacts patient access, and an update on ARM's Grow Internship Program.

Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.

When it comes to furthering AAV's potential in the wider biopharmaceutical pipeline, partnering with a CDMO that can foment an optimal analytical and manufacturing strategy is crucial.

To mitigate the risk of drug failure, understanding a candidate's "developability" is key. By prioritizing developability early, researchers can proactively identify and manage potential roadblocks.

By partnering with the ICLF, see how we were able to gain access to and build trust with influential community leaders and advocates within the African American communities located near study sites.

Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management. Learn how the next generation is both fully scalable and automated.

We are deeply committed to ensuring access to clinical trials for all patients. Learn how to ensure that clinical trials remain accessible to all by supporting efforts to remove financial barriers for participants.